Brief: Hansoh Pharmaceutical Says Clinical Trial Approval For HS-10529 Tablets Issued By NMPA
15/04/2025 16:25
April 15 (Reuters) - Hansoh Pharmaceutical Group Company Ltd 3692.HK: CLINICAL TRIAL APPROVAL FOR HS-10529 TABLETS ISSUED BY NMPA Further company coverage: 3692.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion